VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2
Clinical trial NCT03499795 · COMPLETED
Trial details
- NCT number
- NCT03499795
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2020-06-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.